Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cencora Inc (COR)

Cencora Inc (COR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 49,271,600
  • Shares Outstanding, K 197,047
  • Annual Sales, $ 293,959 M
  • Annual Income, $ 1,509 M
  • EBIT $ 3,685 M
  • EBITDA $ 4,804 M
  • 60-Month Beta 0.45
  • Price/Sales 0.17
  • Price/Cash Flow 12.79
  • Price/Book 63.00

Options Overview Details

View History
  • Implied Volatility 17.87% ( -0.17%)
  • Historical Volatility 20.52%
  • IV Percentile 43%
  • IV Rank 24.46%
  • IV High 29.87% on 10/31/24
  • IV Low 13.98% on 05/17/24
  • Put/Call Vol Ratio 1.34
  • Today's Volume 519
  • Volume Avg (30-Day) 2,052
  • Put/Call OI Ratio 1.39
  • Today's Open Interest 96,828
  • Open Int (30-Day) 94,786

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 3.50
  • Number of Estimates 7
  • High Estimate 3.56
  • Low Estimate 3.42
  • Prior Year 3.28
  • Growth Rate Est. (year over year) +6.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
231.92 +7.82%
on 11/05/24
253.27 -1.27%
on 11/29/24
+15.78 (+6.74%)
since 11/01/24
3-Month
218.65 +14.36%
on 10/07/24
253.27 -1.27%
on 11/29/24
+6.33 (+2.60%)
since 09/03/24
52-Week
195.83 +27.69%
on 12/14/23
253.27 -1.27%
on 11/29/24
+45.96 (+22.52%)
since 12/01/23

Most Recent Stories

More News
GEHC Stock Up Following New Tie-Up to Boost Cancer Research and Care

GE HealthCare Technologies Inc. GEHC announced its collaboration with Melbourne, Australia-based Peter MacCallum Cancer Centre on Monday. The tie-up will enable GEHC to further develop and explore the...

GMED : 85.10 (+1.43%)
COR : 250.05 (+0.07%)
GEHC : 82.57 (-0.61%)
CAH : 123.27 (+0.65%)
Top-Ranked ETFs & Stocks to Feast on Thanksgiving and After

According to the Stock Trader’s Almanac, stocks normally offer solid returns on the Wednesday before Thanksgiving and the Friday after combined, albeit at a low volume. Although the trend has dwindled...

USO : 73.04 (+2.82%)
IWS : 138.80 (-0.50%)
AIRR : 85.45 (+0.47%)
COR : 250.05 (+0.07%)
WLDN : 43.11 (-0.65%)
ANF : 154.97 (-1.49%)
VFH : 124.27 (-0.63%)
CCL : 26.11 (+0.46%)
DIA : 447.89 (-0.19%)
Zacks.com featured highlights include Cencora, Raymond James and Cintas

For Immediate ReleaseChicago, IL – November 26, 2024 – Stocks in this week’s article are Cencora, Inc. COR, Raymond James Financial RJF and Cintas Corp. CTAS.Scoop Up These 3 GARP Stocks to Receive...

COR : 250.05 (+0.07%)
CTAS : 222.65 (unch)
RJF : 165.45 (-0.90%)
Scoop up These 3 GARP Stocks to Receive Handsome Returns

If you are looking for a profitable portfolio of stocks offering the best of value and growth investing, try the growth at a reasonable price or GARP strategy.The strategy helps investors gain exposure...

COR : 250.05 (+0.07%)
CTAS : 222.65 (unch)
RJF : 165.45 (-0.90%)
MCK Stock Down Despite Latest Partnership to Boost SCD Treatment

McKesson Corporation’s MCK dedicated business focused on supporting the commercialization of cell and gene therapies, InspiroGene, has been selected by Vertex Pharmaceuticals Incorporated VRTX to expand...

MCK : 617.95 (-0.54%)
COR : 250.05 (+0.07%)
VRTX : 456.97 (-1.88%)
CAH : 123.27 (+0.65%)
Are Wall Street Analysts Predicting Cencora Stock Will Climb or Sink?

Cencora has underperformed the broader market over the past year, and Wall Street analysts appear moderately bullish about the stock’s future.

HON : 226.96 (-1.30%)
$SPX : 6,049.88 (+0.05%)
COR : 250.05 (+0.07%)
PPH : 90.48 (+0.32%)
Medtronic Q2 Earnings and Revenues Top, Stock Down on Trimmed '25 View

Medtronic plc MDT reported adjusted earnings per share (EPS) of $1.26 for the second-quarter fiscal 2025, up 0.8% from the year-ago quarter’s figure. The figure also beat the Zacks Consensus Estimate...

GMED : 85.10 (+1.43%)
COR : 250.05 (+0.07%)
MDT : 85.71 (-0.96%)
ISRG : 541.71 (-0.21%)
Cencora: Fiscal Q4 Earnings Snapshot

Cencora: Fiscal Q4 Earnings Snapshot

COR : 250.05 (+0.07%)
Cencora's Q4 2024 Earnings: What to Expect

Cencora is poised to announce its fourth-quarter results next month, and analysts predict a double-digit growth in the company’s bottom-line figure.

XLV : 146.82 (-0.22%)
$SPX : 6,049.88 (+0.05%)
COR : 250.05 (+0.07%)
Walgreens Stock Rally: 4 Reasons WBA Could Be a Strong Buy

Walgreens Boots Alliance (WBA) is down 60% from its 52-week high, but improving earnings, cost cuts, and a 9.27% dividend yield signal potential recovery.

TGT : 131.45 (+0.56%)
CVS : 59.19 (+0.19%)
WBA : 8.95 (-0.33%)
COR : 250.05 (+0.07%)
AMZN : 213.44 (+1.30%)
WMT : 93.51 (+0.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.

See More

Key Turning Points

3rd Resistance Point 254.26
2nd Resistance Point 253.33
1st Resistance Point 251.69
Last Price 250.05
1st Support Level 249.12
2nd Support Level 248.19
3rd Support Level 246.55

See More

52-Week High 253.27
Last Price 250.05
Fibonacci 61.8% 231.33
Fibonacci 50% 224.55
Fibonacci 38.2% 217.77
52-Week Low 195.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar